S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ARTV Artiva Biotherapeutics Inc

4.31

-0.08 (-1.82%)

Last Updated: 12:07:28

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Artiva Biotherapeutics (NASDAQ:ARTV)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Artiva Biotherapeutics Charts.

Artiva Biotherapeutics (NASDAQ:ARTV)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Artiva Biotherapeutics Charts.

Artiva Biotherapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Friday 28 February 2025 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 28 February 2025 (5 days ago) • Edgar (US Regulatory)

Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
Thursday 20 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 29 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 29 January 2025 (1 month ago) • Edgar (US Regulatory)

Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.
Wednesday 29 January 2025 (1 month ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (4 months ago) • Edgar (US Regulatory)

Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Tuesday 12 November 2024 (4 months ago) • GlobeNewswire Inc.

Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
Monday 11 November 2024 (4 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 22 October 2024 (4 months ago) • Edgar (US Regulatory)

More Artiva Biotherapeutics Inc News Articles

Bell Buckle (PK)

Good Vibrations Shoes (PK)

Impact Fusion (PK)

Adia Nutrition (PK)

Accredited Solutions (PK)

RespireRx Pharmaceuticals (CE)

Voip Pal Com (QB)

NioCorp Developments

Code Green Apparel (PK)

TPT Global Tech (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions